Locus Biosciences' Series A - II Round

Locus Biosciences raised a round of funding on July 20, 2018. Investors include Artis Ventures.

Locus Biosciences is a biotechnology company focusing on the discovery and development of a CRISPR-Cas platform for precision antimicrobials. The company designs and creates novel CRISPR RNAs (guide R…

Articles about Locus Biosciences' Series A - II Round: